Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene's (CNC) fourth-quarter results are likely to reflect growth in premiums and memberships.

Can Lower Managed Care Profits Hurt Centene (CNC) Q4 Earnings?

New Linde PLC

Shortly before noon Friday, the Dow Jones industrials traded 0.13% higher, the S&P 500 down 0.29% and the Nasdaq down 0.46%.

Earnings Previews: BP, Centene, Linde

Cigna

Elevance Health Inc

Humana

Molina Healthcare

UnitedHealth Group

A proposal for lower-than-expected Medicare Advantage rates in 2024 has sent shares of publicly traded health insurers falling.

Health-insurance stocks drop after Medicare Advantage proposes lower rates for 2024

Activision Blizzard

Colgate-Palmolive

CME Group

CVS Health

Keurig Dr Pepper Inc

Paychex

Republic Services

Sysco

2022 has been a bad year for the equity market, with inflation and interest rates being the primary factors weighing on stocks throughout 2022.

10 Large Cap Stocks Trading Close to 52-Week Lows

Recognition Marks Fifth Consecutive Year Centene Honored in Annual Ranking ST. LOUIS , Feb. 1, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has once again been recognized by FORTUNE magazine as one of the World's Most Admired Companies.

CENTENE NAMED TO FORTUNE WORLD'S MOST ADMIRED COMPANIES LIST

This health insurer appears poised to outperform the S&P 500 index for the third consecutive year in 2023.

This Underappreciated Growth Stock Could Have Huge Upside in 2023

Three Military Transition Interns Start January 2023. ARLINGTON, Va.

Health Net Federal Services Welcomes New Interns from the Department of Defense SkillBridge Program

ST. LOUIS , Jan. 23, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that it has completed the previously announced divestiture of Magellan Specialty Health to Evolent Health, Inc. (Evolent). "We are pleased to reach another significant milestone in our ongoing portfolio review and value creation plan," said Sarah London, Chief Executive Officer of Centene.

CENTENE COMPLETES DIVESTITURE OF MAGELLAN SPECIALTY HEALTH

ST. LOUIS , Jan. 13, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2022 fourth quarter and full year financial results at approximately 6 a.m. (Eastern Time) on Tuesday, February 7, 2023, and will host a conference call afterwards at approximately 8:30 a.m.

CENTENE CORPORATION SCHEDULES 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS CONFERENCE CALL

Centene's (CNC) California subsidiary receives a contract from the DHCS to better address the health requirements of the state's Medi-Cal members.

Centene (CNC) Wins Contract From DHCS to Serve Medi-Cal Members

Centene's (CNC) health benefits ratio is expected to improve in the coming days, signaling better operating efficiency.

Why Hold Strategy is Apt for Centene (CNC) Stock Right Now

Centene Corp. CNC, +0.35% raised on Tuesday the low end of its 2024 profit outlook, after the healthcare services provider announced new Medi-Cal direct contracts. The company said it raised its projected floor for 2024 adjusted earnings per share to $7.15; at Centene's investor day on Dec. 16, the company said it targeted 2024 adjusted EPS of $7.00 to $7.50+.

Centene boosts 2024 profit outlook after new Medi-Cal contracts from DHCS

Health Net to Serve Members in 10 counties including Los Angeles and Sacramento Counties ST. LOUIS , Jan. 3, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today the California Department of Health Care Services (DHCS) has selected its California subsidiary Health Net of California (Health Net) for direct contracts in Los Angeles and Sacramento counties, increasing the number of direct county contracts by DHCS to 10.

CENTENE'S HEALTH NET ISSUED NEW MEDI-CAL DIRECT CONTRACTS BY CALIFORNIA DEPARTMENT OF HEALTH CARE SERVICES

Eligible Fresno Residents enrolled across Health Net's lines of business will have full access to Community's three major hospitals in Fresno County. SACRAMENTO, Calif.

Community Health System and Health Net Agree on Multi-year Network Contract

American Airlines

AmerisourceBergen

Boise Cascade

Cardinal Health

Broker-favorite stocks like Cardinal Health (CAH), American Airlines (AAL), Boise Cascade (BCC), AmerisourceBergen (ABC) and Centene (CNC) should be on an investors' watchlist.

5 Broker-Friendly Stocks to Bank On as Volatility Persists

Centene is one of my very few positions that doesn't have a dividend active - and likely never will. The company is an S&P outperformer over time. I've written about the company a few times. This is an update on a solid business in the healthcare space.

Centene: Once Again, With Quality, Now A 'Buy'

A well-performing government business might aid the Medical-HMO industry. However, expenses incurred for technology advancements and a shortage of nurses will dampen margins.

4 HMO Stocks in Focus Despite Tech Costs, Nursing Shortage

Health Net Assisting Members in Humboldt County During State of Emergency SACRAMENTO, Calif. , Dec. 21, 2022 /PRNewswire/ -- In response to Gov.

Health Net Providing Special Assistance to Members Affected by Earthquake

ST. LOUIS , Dec. 20, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the JP Morgan 41st Annual Healthcare Conference, to be held Monday, January 9-Thursday, January 12, 2023, at the Westin St. Francis in California. Centene will present on Monday, January 9 th at 7:30 a.m.

CENTENE TO PRESENT AT JP MORGAN 41st ANNUAL HEALTHCARE CONFERENCE

Centene's (CNC) board boosts its share buyback program with a new $2-billion fund.

Here's What You Should Know From Centene's (CNC) 2023 Outlook

The company also ranked #1 as a top provider of customer service among health insurance plans for a second year in a row. SACRAMENTO, Calif.

Newsweek Names Health Net Among America's Greatest Workplaces 2023 for Diversity

Centene Corp. set guidance for 2023 on Friday and said it expects revenue for the year to range from $137.4 billion to $139.4 billion. The current FactSet consensus is for revenue of $144.3 billion.

Centene sets guidance for 2023 ahead of investor day

2023 Adjusted Diluted EPS of $6.25 to $6.40 Announces Long-Term Adjusted Diluted EPS CAGR Target of 12% - 15% Board Authorizes $2 Billion Increase to Stock Repurchase Program ST. LOUIS , Dec. 16, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today will host its investor day to outline its 2023 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value.

CENTENE CORPORATION ANNOUNCES 2023 GUIDANCE

Ken Fasola named President of Centene Jim Murray named Chief Operating Officer Brent Layton becomes Senior Advisor to the CEO  Dave Thomas becomes Chief Executive Officer of Markets and Medicaid  Additionally, Company appoints Alice H. Chen, MD, MPH as Chief Health Officer and Brian LeClaire, MBA, PhD, as Chief Information Officer ST.

CENTENE CORPORATION ANNOUNCES LEADERSHIP CHANGES AND APPOINTMENTS FOR NEXT PHASE OF GROWTH

Centene (CNC) collaborates with CHDI to establish a new community center in Texas, reflecting efforts to expand its Managed Care business across the state.

News for Centene Stock (CNC)